HomeInsightsPE

Advanced Enzyme Technologies Ltd PE Ratio

Advanced Enzyme Technologies Ltd PE Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

12.5 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES

PE

27.9

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Advanced Enzyme Technologies Ltd is 27.9 as of 23 Nov 15:30 PM .
  • The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 18.4 on March 2019 to 29.1 on March 2024 . This represents a CAGR of 7.94% over 6 years.
  • The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 366.65 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Advanced Enzyme Technologies Ltd

No data available

Company Fundamentals for Advanced Enzyme Technologies Ltd

No data available

Image

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES

Share Price

₹ 366.65

-4.40 (-1.19%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Advanced Enzyme Technologies Ltd

1M

1Y

3Y

5Y

Monitoring Advanced Enzyme Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024366.65
21 Nov 2024371.05
19 Nov 2024378.05
18 Nov 2024379.85
14 Nov 2024380.05
13 Nov 2024378.55
12 Nov 2024401.15
11 Nov 2024410.45
08 Nov 2024485.55
07 Nov 2024493.6

SWOT Analysis Of Advanced Enzyme Technologies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Advanced Enzyme Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Advanced Enzyme Technologies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Advanced Enzyme Technologies Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Advanced Enzyme Technologies Ltd

No data available

* All values are in crore

Historical Revenue of Advanced Enzyme Technologies Ltd

No data available

* All values are in crore

Historical EBITDA of Advanced Enzyme Technologies Ltd

No data available

* All values are in crore

Historical Net Profit of Advanced Enzyme Technologies Ltd

No data available

* All values are in crore

Historical Dividend Payout of Advanced Enzyme Technologies Ltd

No data available

* All values are in %

About Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes.
  • Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra.
  • The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
  • Again, the name was changed to Advanced Enzyme Technologies Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA.

Advanced Enzyme Technologies Ltd News Hub

News

Advanced Enzyme Technologies consolidated net profit rises 18.54% in the June 2024 quarter

Net profit of Advanced Enzyme Technologies rose 18.54% to Rs 34.15 crore in the quarter en...

Read more

2024-08-10 00:00:00

News

Advanced Enzyme Techs. announces board meeting date

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

2024-08-03 00:00:00

News

Advanced Enzyme Tech drops after Q2 PAT slides 5% YoY

The revenue de-grew by 3% in Americas, 27% in Europe, 9% in Asia (ex-India) while it grew ...

Read more

2024-11-11 00:00:00

News

Advanced Enzyme Techs. announces board meeting date

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 N...

Read more

2024-11-02 00:00:00

News

Advanced Enzyme Techs. to table results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 N...

Read more

2024-10-31 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Advanced Enzyme Technologies Ltd

What is the current PE Ratio of Advanced Enzyme Technologies Ltd?

The Current PE Ratio of Advanced Enzyme Technologies Ltd is 27.86 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Advanced Enzyme Technologies Ltd last year?

The PE Ratio of Advanced Enzyme Technologies Ltd was 24.51 last year, now the PE ratio is 27.86, showing a year-on-year growth of 13.7%.

What does the PE Ratio of Advanced Enzyme Technologies Ltd indicate about its stock?

The PE Ratio of Advanced Enzyme Technologies Ltd is 27.86. This ratio indicates that investors are willing to pay 27.86 times the earnings per share for each share of Advanced Enzyme Technologies Ltd.

What is the PE Ratio Growth of Advanced Enzyme Technologies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Advanced Enzyme Technologies Ltd grew by 13.7% whereas, the EPS ratio grew by -3.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*